| Dr Desiree Lynn Poppens, PSYD | |
|
2501 W 22nd St, Sioux Falls, SD 57105-1305 | |
| (605) 336-3230 | |
| Not Available |
| Full Name | Dr Desiree Lynn Poppens |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 2501 W 22nd St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538576400 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 0004873 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Desiree Lynn Poppens, PSYD 46845 275th St, Lennox, SD 57039-5310 Ph: (909) 720-8325 | Dr Desiree Lynn Poppens, PSYD 2501 W 22nd St, Sioux Falls, SD 57105-1305 Ph: (605) 336-3230 |
News Archive
Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.
An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results of which set the stage to expand the use of a patient's genetic make-up to tailor chemotherapy.
NorthStar Healthcare Income, Inc. (NorthStar Healthcare) announced that it recently invested more than $170.0 million in two healthcare real estate transactions, including one assisted living portfolio acquisition and one mezzanine loan backed by a portfolio of skilled nursing and assisted living facilities.
America's seniors suffer a disproportionate burden of oral disease while having fewer resources for appropriate care - and these issues will be exacerbated as the elderly population grows.
Neurologix, Inc. today announced that a landmark paper, published on October 20th in Science Translational Medicine demonstrating the importance of the p11 gene in modulating depression in mice, utilized a gene therapy approach to reverse depression in mice for which the Company holds exclusive development rights. Based on the findings reported in the paper, gene therapy may have potential as a new treatment option for people who suffer from severe depression.
› Verified 2 days ago
Dr. Rachel Mcclure, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2501 W 22nd St, Sioux Falls, SD 57105 Phone: 605-336-3230 | |
Dr. Thomas Charles Himler, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1100 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-332-3706 | |
Joel Sonnichsen, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 201 E 38th St, Sioux Falls, SD 57105 Phone: 605-367-7924 | |
Nancy Ann Johnson, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4400 W. 69th St., Ste. 1500, Sioux Falls, SD 57108 Phone: 605-322-5700 Fax: 605-322-5704 | |
Ashton Moody, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 201 E 38th St, Sioux Falls, SD 57105 Phone: 605-367-7924 | |
Dr. Jennifer Kae Helkenn, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2109 S Norton Ave, Sioux Falls, SD 57105 Phone: 605-334-2696 | |
Brenda Michelle Lindsay Nour, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4400 W 69th St Ste 1500, Sioux Falls, SD 57108 Phone: 605-480-1482 |